Pakistan

Last Updated 14 June 2021.

5 Vaccines Approved for Use in Pakistan

• CanSino
  Ad5-nCoV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 5 countries

  8 trials in 6 countries

  Non Replicating Viral Vector

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  19 trials in 6 countries

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 110 countries

  32 trials in 19 countries

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  BBIBP-CorV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 53 countries

  6 trials in 7 countries

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 29 countries

  15 trials in 7 countries

  Inactivated

2 Vaccines in Clinical Trials in Pakistan

• Anhui Zhifei Longcom
  RBD-Dimer

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  6 trials in 5 countries

  Protein Subunit

• CanSino
  Ad5-nCoV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 5 countries

  8 trials in 6 countries

  Non Replicating Viral Vector